Trademarkia Logo

Canada

C$
REZNARE
REGISTERED

on 29 Jul 2019

Last Applicant/ Owned by

PFIZER INC.

66 Hudson Boulevard EastNew York, New York 10001-2192

US

Serial Number

1719530 filed on 16th Mar 2015

Registration Number

TMA1045271 registered on 29th Jul 2019

Registration expiry Date

29th Jul 2029

Correspondent Address

TORYS LLP

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

REZNARE

Trademark usage description

pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, a Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, anxiety and cognitive disorders, seizure disorders, Alzheimer's disease, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis; Pharmaceutical preparations for the prevention and treatment of cranial and facial nerve disorders, connective tissue injuries, diseases and disorders, bone and cartilage injuries, diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neuromuscular and neurological diseases and disorders, namely, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, muscle diseases and disorders, namely inflammatory muscle diseases and disorders, and muscular dystrophy, ocular motility and spinal cord infections, injuries and diseases, and seizure disorders; Pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, inflammatory pelvic diseases, urological and reproductive system diseases, disorders and infections, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence; Pharmaceutical preparations for the prevention and treatment of auto-immune, cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of allergies, hypertension, menopause, diabetic neuropathy, and pain; Antibiotics, anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectable pharmaceutical contraceptives, human vaccines; Pharmaceutical preparations for the treatment of smoking cessation; Pharmaceutical preparations for the prevention and treatment of renal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the prevention and treatment of muscular atrophy; Pharmaceutical preparations for the prevention and treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, muscular dystrophy, sickle cell disease, and anemia.


Classification kind code

10

Mark Details


Serial Number

1719530

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 22nd Mar 2017
Advertised
Submitted for opposition 26
on 2th Mar 2017
Approved
Submitted for opposition 27
on 10th Jan 2017
Approval Notice Sent
Submitted for opposition 15
on 29th Jul 2016
Correspondence Created
Submitted for opposition 15
on 21st Dec 2015
Correspondence Created
Submitted for opposition 22
on 9th Sept 2015
Search Recorded
Submitted for opposition 20
on 9th Sept 2015
Examiner's First Report
Submitted for opposition 31
on 20th Mar 2015
Formalized
Submitted for opposition 1
on 17th Mar 2015
Created
Submitted for opposition 30
on 16th Mar 2015
Filed